| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.51 | 0.09 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.35 | 0.2 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.26 | 0.1 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.26 | 0.1 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.25 | 1e-06 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.25 | 0.1 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.24 | 0.1 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.23 | 0.1 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.22 | 0.2 |